Last update 08 May 2025

PUR-003

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Immune System DiseasesInfectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
AsthmaCOVID-19Influenza, Human
Originator Organization
Pulmatrix, Inc.Pulmatrix, Inc.
Active Organization-
Inactive Organization
Pulmatrix, Inc.Pulmatrix, Inc.Sensory Cloud, Inc.Sensory Cloud, Inc.
License Organization
Sensory Cloud, Inc.Sensory Cloud, Inc.
Pulmatrix, Inc.Pulmatrix, Inc.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with PUR-003
NCT00989521
/ CompletedPhase 1
Double-blind, Placebo-controlled Crossover Evaluation of the Effect of PUR003 on Subjects With Asthma
NCT00947687
/ CompletedPhase 1
A Randomized, Phase 1B, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects
100 Clinical Results associated with PUR-003
Login to view more data
100 Translational Medicine associated with PUR-003
Login to view more data
100 Patents (Medical) associated with PUR-003
Login to view more data
100 Deals associated with PUR-003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 1
Canada
Sensory Cloud, Inc.Sensory Cloud, Inc.
16 Apr 2020
AsthmaPhase 1
Canada
Pulmatrix, Inc.Pulmatrix, Inc.
01 Dec 2009
Influenza, HumanPhase 1
United Kingdom
Pulmatrix, Inc.Pulmatrix, Inc.
01 Jul 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free